CB2 receptor agonist 8
Product Specifications
UNSPSC Description
CB2 receptor agonist 8 (Compound 17) is an agonist for cannabinoid receptor 2 (CB2 receptor). CB2 receptor agonist 8 exhibits cytotoxicity in cells U87, RPMI 8226, HL-60, and L929 with IC50s of 91.03, 16.29, 23.51 and 564.6 μM, respectively. CB2 receptor agonist 8 activates caspase 3/7, increases the expressions of pro-apoptotic genes BAX, BAD, BIM and tumor suppressor genes p53, and induces apoptosis in U87. CB2 receptor agonist 8 inhibits the migration of U87[1].
Target Antigen
Cannabinoid Receptor; Caspase
Type
Reference compound
Related Pathways
Apoptosis;GPCR/G Protein;Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cb2-receptor-agonist-8.html
Smiles
O=C(N[C@H](C(N)=O)C(C)(C)C)CC1=CN(CC2=CC=CC=C2)C3=CC=C(F)C=C31
Molecular Weight
395.47
References & Citations
[1]Doganc F, et al., Synthesis of novel indol-3-acetamido analogues as potent anticancer agents, biological evaluation and molecular modeling studies. Bioorg Chem. 2024 Jul;148:107429.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-168338/CB2-receptor-agonist-8-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-168338/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![HDAC11 Mouse Monoclonal Antibody [Clone ID: LBI7H10]](https://cdn.genprice.uk/genprice/genprice3.png)
